Position in VTRS
as of Mar 31, 2026
· filed Apr 13, 2026
Position Value
$26,265,777
-$7,077,825 QoQ
Shares Held
1,944,173
-27.4% QoQ
Ownership
0.167%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
5 quarters on record
Voting authority
Sole 71.4850478841132.ToString("F0")%
Shared 0.ToString("F0")%
None 28.514952115886803.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026WEDGE CAPITAL MANAGEMENT L L P/NC holds $76,652,917 across 8 Drug Manufacturers - Specialty & Generic names. VTRS ranks #2 (34.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
54,673 | $32,419,995 | |
| 2 | VTRS |
Viatris Inc
This page
|
1,944,173 | $26,265,777 | |
| 3 | ALKS |
Alkermes plc.
|
151,234 | $5,347,634 | |
| 4 | SUPN |
Supernus Pharmaceuticals, Inc.
|
69,643 | $3,599,846 | |
| 5 | PBH |
Prestige Consumer Healthcare Inc.
|
54,034 | $3,202,595 | |
| 6 | COLL |
Collegium Pharmaceutical, Inc
|
71,353 | $2,359,643 | |
| 7 | IRWD |
Ironwood Pharmaceuticals Inc
|
540,492 | $1,897,126 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
20,290 | $1,560,301 |
All Filings in VTRS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $26,265,777 | 1,944,173 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $33,343,602 | 2,678,201 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $23,666,346 | 2,390,540 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $30,090,617 | 3,369,610 | Shares | Sole | 2025-07-11 | |
| 2021-12-31 | $35,397,510 | 2,616,224 | Shares | Sole | 2022-01-24 | |
| No filing history on record for this holder in this stock. | ||||||